Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
Susan Colilla(Teva Pharmaceuticals (United States)), Xianchen Liu(Shandong University), Daniel E. Singer(Massachusetts General Hospital), William Petkun(Bristol-Myers Squibb (United States)), Ann Crow(Bristol-Myers Squibb (United States)), Teresa A. Simon(Bristol-Myers Squibb (Germany))
Cited by 1,321
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
|New England Journal of Medicine|2003|1.3k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
|Journal of the American College of Cardiology|2011|851